Align Technology (ALGN)
NASDAQ: ALGN · Medical Devices · Tempe, AZ
Our rating: Neutral
Call changed from Cautious to Neutral at $159.37, moderate conviction, November 5, 2026.
Breaks if: The Neutral call turns Cautious if two consecutive quarters show year-over-year revenue decline, or if the FCF margin falls below 10% on a trailing basis within the next 12 months (it runs near 12% today). It turns Positive if trailing twelve-month revenue growth reaccelerates to 8% or above within the same 12-month window.
Key figures
| Market value | $10.9B |
|---|---|
| Revenue, last 12 months | $4.2B |
| Net income, last 12 months | $492M |
| Free cash flow, last 12 months | $603M |
| Price to earnings | 22.2× |
| Free cash flow yield | 5.5% |
| Dividend yield | 0.0% |
| Operating margin | 14.9% |
| Return on equity | 11.9% |
| Beta to the S&P 500 | 1.26 |
| Volatility, annualized | 45.7% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $1.0B | 1.9% | $1.90 | $138M |
| June 30, 2026 | $1.1B | 4.3% | $1.51 | $157M |
| March 31, 2026 | $1.0B | 6.2% | $1.57 | $120M |
| December 31, 2025 | $1.0B | 5.3% | $1.88 | $187M |
| September 30, 2025 | $996M | 1.8% | $0.78 | $169M |
| June 30, 2025 | $1.0B | −1.6% | $1.72 | $107M |
| March 31, 2025 | $979M | −1.8% | $1.27 | $27M |
| December 31, 2024 | $995M | 4.0% | $1.39 | $263M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $1.09B: Claude 32%, Gemini 40%, Mistral 45%
- Diluted earnings per share are at least $1.88: Claude 48%, Gemini 75%, Mistral 60%
- Free cash flow for the quarter is at least $0.19B: Claude 33%, Gemini 35%, Mistral 55%
12 ledger entries and 66 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.